Epstein Secrets

l Meeting EFTA_R1_02010990 EFTA02686116 Martin Dahinden Weili Dai Omotayo Dairo Henk Dalen Elizabeth Daley Charles H. Dallara James Dallas Luke J. Daly Winston Damarillo Kommer Damen Brian A. Dames Dang Thanh Tam Aliko Dangote John Eric Daniels Ronald J. Daniels John Daniszewski Richard Danzig

cutive Officer Business Editor Secretary-General Chief Executive Officer Chief Executive Officer Managing Director, Legal and Risk Professor of Management Practice President, Merck Vaccines Director, Center for Public Leadership Artistic and General Director Managing Partner, Strategy and Business Developme

Vice-President, Quality and Medtronic Inc. USA Operations John Dalli Commissioner, Health and Consumer Policy, European Commission, Brussels Luke J. Daly Founder and Chief Executive Officer Ferrate Treatment USA Technologies Winston DamanIlo Chief Executive Officer Morphlabs Inc. USA Kommer Da

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi

Vice-President, Quality and Medtronic Inc. USA Operations John Dalli Commissioner, Health and Consumer Policy, European Commission, Brussels Luke J. Daly Founder and Chief Executive Officer Ferrate Treatment USA Technologies Winston DamanIlo Chief Executive Officer Morphlabs Inc. USA Kommer Da

Executive Officer Amdocs Management Ltd USA Pierre Gentin Managing Director, Legal and Risk Credit Suisse USA William W. George Professor of Management Practice Harvard Business School USA Julie Louise Gerberding President, Merck Vaccines Merck & Co. Inc. USA David R. Gergen Director, Center for Publi